Interdisciplinary Study Group of Lupus Erythematosus (ISGLE) - Trial NCT00420173
Access comprehensive clinical trial information for NCT00420173 through Pure Global AI's free database. This phase not specified trial is sponsored by European Society of Cutaneous Lupus Erythematosus e.V. and is currently Completed. The study focuses on Cutaneous Lupus Erythematosus. Target enrollment is 45 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
European Society of Cutaneous Lupus Erythematosus e.V.
Timeline & Enrollment
N/A
Sep 01, 2004
Jun 01, 2008
Summary
Cutaneous lupus erythematosus (CLE) is a disease with a wide spectrum of clinical
 manifestations and a variable prognosis. The aim of this study is to create a standardized
 evaluation of the different subtypes of this disease in order to receive an overview of the
 spectrum of clinical and laboratory features as well as the therapeutic strategies for
 patients with CLE.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT00420173
Non-Device Trial